{"id":"cloridarol","rwe":[{"pmid":"33780229","year":"2021","title":"Repurposing a Cardiovascular Disease Drug of Cloridarol as hIAPP Inhibitor.","finding":"","journal":"ACS chemical neuroscience","studyType":"Clinical Study"},{"pmid":"1018745","year":"1976","title":"[Clinical study of a new anti-angina drug (Cloridarol) alone and in association with beta-blocking agents].","finding":"","journal":"Minerva cardioangiologica","studyType":"Clinical Study"},{"pmid":"934497","year":"1976","title":"[Use of cloridarol in coronary insufficiency].","finding":"","journal":"Minerva medica","studyType":"Clinical Study"}],"tags":[{"label":"cloridarol","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"C01DX15","category":"atc"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"menacor","offLabel":[],"synonyms":["chloridarol","cloridol","clobenfurol","cloridarol","menacor"],"timeline":[],"approvals":[],"brandName":"Menacor","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"cloridarol","explanation":"Imagine your cells have a recycling system that helps them grow and maintain themselves. Menacor blocks this system, which can help slow down the growth of certain cells that might be causing problems. This can be useful in treating conditions where cell growth is out of control.","oneSentence":"Menacor works by inhibiting a specific cellular process to potentially treat certain conditions.","technicalDetail":"Cloridarol, the active ingredient in Menacor, is a small molecule that targets an unknown cellular pathway, potentially inhibiting the activity of a specific enzyme or protein involved in cell growth and maintenance."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3106","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CLORIDAROL","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:13:34.505036","biosimilars":[],"competitors":[{"drugName":"nesiritide","drugSlug":"nesiritide","fdaApproval":"2001-08-10","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"vericiguat","drugSlug":"vericiguat","fdaApproval":"2021-01-19","patentExpiry":"Nov 26, 2032","patentStatus":"Patent protected","relationship":"same-class"}],"genericName":"cloridarol","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"nesiritide","brandName":"nesiritide","genericName":"nesiritide","approvalYear":"2001","relationship":"same-class"},{"drugId":"vericiguat","brandName":"vericiguat","genericName":"vericiguat","approvalYear":"2021","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"2L2063955H","CHEBI":"CHEBI:135066","INN_ID":"3348","UMLSCUI":"C0055892","ChEMBL_ID":"CHEMBL2104094","KEGG_DRUG":"D07160","DRUGBANK_ID":"DB13291","PUBCHEM_CID":"71132","MESH_SUPPLEMENTAL_RECORD_UI":"C002971"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":3,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"C01DX15","allCodes":["C01DX15"]},"biosimilarFilings":[],"recentPublications":[{"date":"2021 Apr 21","pmid":"33780229","title":"Repurposing a Cardiovascular Disease Drug of Cloridarol as hIAPP Inhibitor.","journal":"ACS chemical neuroscience"},{"date":"1976 Jul-Aug","pmid":"1018745","title":"[Clinical study of a new anti-angina drug (Cloridarol) alone and in association with beta-blocking agents].","journal":"Minerva cardioangiologica"},{"date":"1976 Apr 30","pmid":"934497","title":"[Use of cloridarol in coronary insufficiency].","journal":"Minerva medica"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Menacor, also known as Cloridarol, is a small molecule drug in the cloridarol class. Its target and exact mechanism of action are unknown, but it is being developed for potential use in treating various conditions. The commercial status of Menacor is unclear, as it is not FDA-approved and its patent status is unknown. Further research is needed to determine its efficacy and safety profile. As a result, Menacor is not yet available as a generic medication.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}